avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.6 | trans-acting transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | mm10_v2_chr15_+_102406143_102406380 | -0.65 | 2.0e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_105269837 | 19.89 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr8_+_105269788 | 19.52 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr1_+_74332596 | 19.24 |
ENSMUST00000087225.5
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr10_-_88503952 | 17.12 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr2_+_58567360 | 16.68 |
ENSMUST00000071543.5
|
Upp2
|
uridine phosphorylase 2 |
chr19_+_46131888 | 16.30 |
ENSMUST00000043739.3
|
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr18_-_38211957 | 15.77 |
ENSMUST00000159405.1
ENSMUST00000160721.1 |
Pcdh1
|
protocadherin 1 |
chr12_+_108334341 | 15.36 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr12_-_84450944 | 15.14 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr11_-_120660565 | 15.12 |
ENSMUST00000106177.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr2_+_155517948 | 14.86 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr7_-_99626936 | 14.65 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chrX_+_36598199 | 14.58 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr2_-_148045891 | 14.38 |
ENSMUST00000109964.1
|
Foxa2
|
forkhead box A2 |
chr10_-_88503912 | 14.07 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr17_-_45686120 | 13.95 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chrX_-_73716145 | 13.73 |
ENSMUST00000002091.5
|
Bcap31
|
B cell receptor associated protein 31 |
chr3_-_89393629 | 13.68 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr11_+_94211431 | 13.50 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr17_-_57059795 | 13.33 |
ENSMUST00000040280.7
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr2_-_73386396 | 13.24 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr7_-_81454751 | 13.23 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr16_+_44173271 | 13.15 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr18_+_64340225 | 13.14 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr17_-_45685973 | 12.86 |
ENSMUST00000145873.1
|
Tmem63b
|
transmembrane protein 63b |
chr10_+_80329953 | 12.71 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr7_+_44384098 | 12.69 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr10_-_88504073 | 12.64 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr8_+_114133601 | 12.48 |
ENSMUST00000109109.1
|
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr4_+_43046014 | 12.36 |
ENSMUST00000180426.1
|
Gm26881
|
predicted gene, 26881 |
chr16_+_44173239 | 12.15 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr4_-_114908892 | 11.99 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr7_-_43489967 | 11.97 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr3_-_18243289 | 11.87 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr9_+_47530173 | 11.60 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr11_-_102296618 | 11.51 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr5_-_53213447 | 11.18 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr16_-_24393588 | 11.08 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr5_+_129941949 | 11.02 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr7_+_44590886 | 11.01 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chrX_-_60403947 | 10.82 |
ENSMUST00000033480.6
ENSMUST00000101527.2 |
Atp11c
|
ATPase, class VI, type 11C |
chr16_-_46496772 | 10.81 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr11_-_120661175 | 10.77 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr4_-_41503046 | 10.74 |
ENSMUST00000054920.4
|
AI464131
|
expressed sequence AI464131 |
chr1_+_72824482 | 10.70 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr11_+_90249469 | 10.69 |
ENSMUST00000004050.6
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr12_+_8771317 | 10.46 |
ENSMUST00000020911.7
|
Sdc1
|
syndecan 1 |
chr13_+_54789500 | 10.42 |
ENSMUST00000163915.1
ENSMUST00000099503.3 ENSMUST00000171859.1 |
Tspan17
|
tetraspanin 17 |
chr9_-_110742577 | 10.35 |
ENSMUST00000006005.7
|
Pth1r
|
parathyroid hormone 1 receptor |
chr1_+_133363564 | 10.02 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr11_+_119942763 | 10.02 |
ENSMUST00000026436.3
ENSMUST00000106231.1 ENSMUST00000075180.5 ENSMUST00000103021.3 ENSMUST00000106233.1 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr19_+_37697792 | 9.95 |
ENSMUST00000025946.5
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr5_+_134986191 | 9.82 |
ENSMUST00000094245.2
|
Cldn3
|
claudin 3 |
chr4_-_41640322 | 9.72 |
ENSMUST00000127306.1
|
Enho
|
energy homeostasis associated |
chr11_+_90249426 | 9.70 |
ENSMUST00000107887.1
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr11_+_101468164 | 9.61 |
ENSMUST00000001347.6
|
Rnd2
|
Rho family GTPase 2 |
chr10_+_63024315 | 9.55 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr7_+_57591147 | 9.55 |
ENSMUST00000039697.7
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr13_+_54789377 | 9.47 |
ENSMUST00000026993.7
ENSMUST00000131692.2 ENSMUST00000163796.1 |
Tspan17
|
tetraspanin 17 |
chr3_-_89393294 | 9.46 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr6_-_119848059 | 9.45 |
ENSMUST00000184864.1
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_-_46991842 | 9.40 |
ENSMUST00000107749.2
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr12_+_8771405 | 9.38 |
ENSMUST00000171158.1
|
Sdc1
|
syndecan 1 |
chr17_-_45686214 | 9.38 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr5_-_65435717 | 9.36 |
ENSMUST00000117542.1
|
Ugdh
|
UDP-glucose dehydrogenase |
chr9_-_108263887 | 9.21 |
ENSMUST00000166905.1
ENSMUST00000080435.2 |
Dag1
|
dystroglycan 1 |
chr7_+_28180226 | 9.13 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr6_-_120294559 | 9.08 |
ENSMUST00000057283.7
|
B4galnt3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
chr13_-_47043116 | 9.01 |
ENSMUST00000110118.1
ENSMUST00000124948.1 ENSMUST00000021806.3 ENSMUST00000136864.1 |
Tpmt
|
thiopurine methyltransferase |
chr10_+_128194631 | 9.00 |
ENSMUST00000123291.1
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_-_129239165 | 8.98 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr8_+_76902277 | 8.95 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr2_-_160872985 | 8.94 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr17_-_24209377 | 8.88 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr9_+_121642716 | 8.85 |
ENSMUST00000035115.4
|
Vipr1
|
vasoactive intestinal peptide receptor 1 |
chr16_+_20733104 | 8.81 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr7_+_28180272 | 8.80 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr12_+_103532435 | 8.76 |
ENSMUST00000021631.5
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr5_+_73491026 | 8.75 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr10_+_128933782 | 8.69 |
ENSMUST00000099112.2
|
Itga7
|
integrin alpha 7 |
chr14_-_25769033 | 8.68 |
ENSMUST00000069180.7
|
Zcchc24
|
zinc finger, CCHC domain containing 24 |
chr2_-_160872829 | 8.63 |
ENSMUST00000176141.1
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr13_+_12565868 | 8.62 |
ENSMUST00000071973.6
|
Ero1lb
|
ERO1-like beta (S. cerevisiae) |
chr14_-_33447142 | 8.56 |
ENSMUST00000111944.3
ENSMUST00000022504.5 ENSMUST00000111945.2 |
Mapk8
|
mitogen-activated protein kinase 8 |
chr4_+_116877376 | 8.51 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr7_+_44384604 | 8.50 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr19_-_4943049 | 8.44 |
ENSMUST00000133254.1
ENSMUST00000120475.1 ENSMUST00000025834.7 |
Peli3
|
pellino 3 |
chr7_-_19699008 | 8.28 |
ENSMUST00000174355.1
ENSMUST00000172983.1 ENSMUST00000174710.1 ENSMUST00000167646.2 ENSMUST00000003066.9 ENSMUST00000174064.1 |
Apoe
|
apolipoprotein E |
chr1_-_93478785 | 8.28 |
ENSMUST00000170883.1
|
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr15_-_100599983 | 8.28 |
ENSMUST00000073837.6
|
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr6_-_119848120 | 8.27 |
ENSMUST00000183703.1
ENSMUST00000183911.1 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_+_117252010 | 8.25 |
ENSMUST00000125943.1
ENSMUST00000106434.1 |
Tmem53
|
transmembrane protein 53 |
chr19_+_44989073 | 8.25 |
ENSMUST00000026225.8
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr7_-_16614937 | 8.25 |
ENSMUST00000171937.1
ENSMUST00000075845.4 |
Grlf1
|
glucocorticoid receptor DNA binding factor 1 |
chr11_-_87987528 | 8.24 |
ENSMUST00000020775.2
|
Dynll2
|
dynein light chain LC8-type 2 |
chrX_+_161717498 | 8.18 |
ENSMUST00000061514.7
|
Rai2
|
retinoic acid induced 2 |
chr10_+_128194446 | 8.18 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr6_-_124917939 | 8.17 |
ENSMUST00000032216.6
|
Ptms
|
parathymosin |
chrX_-_160994665 | 8.16 |
ENSMUST00000087104.4
|
Cdkl5
|
cyclin-dependent kinase-like 5 |
chr11_+_98348404 | 8.16 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_+_117251951 | 8.14 |
ENSMUST00000062824.5
|
Tmem53
|
transmembrane protein 53 |
chr11_-_74925925 | 8.01 |
ENSMUST00000121738.1
|
Srr
|
serine racemase |
chr8_+_114133557 | 7.98 |
ENSMUST00000073521.5
ENSMUST00000066514.6 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr9_+_37613806 | 7.97 |
ENSMUST00000002007.3
|
Siae
|
sialic acid acetylesterase |
chr7_-_100658394 | 7.97 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr6_-_146502099 | 7.93 |
ENSMUST00000053273.8
|
Itpr2
|
inositol 1,4,5-triphosphate receptor 2 |
chr19_-_46148369 | 7.91 |
ENSMUST00000026259.9
|
Pitx3
|
paired-like homeodomain transcription factor 3 |
chr2_-_160872552 | 7.87 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr2_-_130642770 | 7.84 |
ENSMUST00000045761.6
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr9_+_55326913 | 7.81 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr10_-_127620960 | 7.80 |
ENSMUST00000121829.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr7_-_27333602 | 7.79 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr15_-_31367527 | 7.75 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr5_-_31295862 | 7.74 |
ENSMUST00000041266.7
ENSMUST00000172435.1 |
Fndc4
|
fibronectin type III domain containing 4 |
chr9_-_108263706 | 7.72 |
ENSMUST00000171412.1
|
Dag1
|
dystroglycan 1 |
chr11_+_102393403 | 7.70 |
ENSMUST00000107105.2
ENSMUST00000107102.1 ENSMUST00000107103.1 ENSMUST00000006750.7 |
Rundc3a
|
RUN domain containing 3A |
chr10_-_127620922 | 7.69 |
ENSMUST00000118455.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr1_-_121328024 | 7.69 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr15_-_86033777 | 7.68 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chr5_-_65435881 | 7.66 |
ENSMUST00000031103.7
|
Ugdh
|
UDP-glucose dehydrogenase |
chr7_-_100658364 | 7.66 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr4_+_148130883 | 7.65 |
ENSMUST00000084129.2
|
Mad2l2
|
MAD2 mitotic arrest deficient-like 2 |
chr7_+_97332311 | 7.65 |
ENSMUST00000054107.5
|
Kctd21
|
potassium channel tetramerisation domain containing 21 |
chr12_-_108275409 | 7.61 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr9_+_80165079 | 7.61 |
ENSMUST00000184480.1
|
Myo6
|
myosin VI |
chr11_+_55098104 | 7.58 |
ENSMUST00000000608.7
|
Gm2a
|
GM2 ganglioside activator protein |
chr9_+_57697612 | 7.58 |
ENSMUST00000034865.4
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr8_-_91801948 | 7.55 |
ENSMUST00000175795.1
|
Irx3
|
Iroquois related homeobox 3 (Drosophila) |
chr7_-_140154712 | 7.53 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr18_+_84088077 | 7.52 |
ENSMUST00000060223.2
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chrX_+_73716577 | 7.48 |
ENSMUST00000002084.7
|
Abcd1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
chr3_-_89322883 | 7.47 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr14_+_21052574 | 7.38 |
ENSMUST00000045376.9
|
Adk
|
adenosine kinase |
chr4_-_107307118 | 7.38 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr14_+_55575617 | 7.38 |
ENSMUST00000022826.5
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr12_+_108792946 | 7.38 |
ENSMUST00000021692.7
|
Yy1
|
YY1 transcription factor |
chr7_-_30924169 | 7.36 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr7_-_34654342 | 7.35 |
ENSMUST00000108069.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr16_-_46496955 | 7.32 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr15_+_99295087 | 7.28 |
ENSMUST00000128352.1
ENSMUST00000145482.1 |
Prpf40b
|
PRP40 pre-mRNA processing factor 40 homolog B (yeast) |
chr2_-_168741752 | 7.26 |
ENSMUST00000029060.4
|
Atp9a
|
ATPase, class II, type 9A |
chr2_+_31470207 | 7.22 |
ENSMUST00000102840.4
|
Ass1
|
argininosuccinate synthetase 1 |
chr16_-_17928136 | 7.20 |
ENSMUST00000003622.8
|
Slc25a1
|
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
chr2_-_33371400 | 7.18 |
ENSMUST00000113164.1
ENSMUST00000091039.2 ENSMUST00000042615.6 |
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr6_-_119848093 | 7.15 |
ENSMUST00000079582.4
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr4_-_108118504 | 7.12 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr16_+_64851991 | 7.11 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr18_-_61911783 | 7.09 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr13_-_29984219 | 7.06 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr15_+_76696725 | 7.05 |
ENSMUST00000023203.4
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr8_-_84800024 | 7.05 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr14_+_55560904 | 6.99 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr10_+_127380591 | 6.97 |
ENSMUST00000166820.1
|
R3hdm2
|
R3H domain containing 2 |
chr18_-_3337539 | 6.96 |
ENSMUST00000142690.1
ENSMUST00000025069.4 ENSMUST00000082141.5 ENSMUST00000165086.1 ENSMUST00000149803.1 |
Crem
|
cAMP responsive element modulator |
chrX_-_162888426 | 6.96 |
ENSMUST00000033723.3
|
Syap1
|
synapse associated protein 1 |
chr11_-_74925658 | 6.96 |
ENSMUST00000138612.1
ENSMUST00000123855.1 ENSMUST00000128556.1 ENSMUST00000108448.1 ENSMUST00000108447.1 ENSMUST00000065211.2 |
Srr
|
serine racemase |
chr15_-_3583146 | 6.88 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr16_-_20621255 | 6.88 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr9_-_31211805 | 6.85 |
ENSMUST00000072634.7
ENSMUST00000079758.7 |
Aplp2
|
amyloid beta (A4) precursor-like protein 2 |
chr2_-_65022740 | 6.83 |
ENSMUST00000028252.7
|
Grb14
|
growth factor receptor bound protein 14 |
chr19_+_53903351 | 6.81 |
ENSMUST00000025931.6
ENSMUST00000165617.1 |
Pdcd4
|
programmed cell death 4 |
chr11_+_75193783 | 6.77 |
ENSMUST00000102514.3
|
Rtn4rl1
|
reticulon 4 receptor-like 1 |
chr1_-_65179058 | 6.75 |
ENSMUST00000097709.4
|
Idh1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chrX_+_161717055 | 6.74 |
ENSMUST00000112338.1
|
Rai2
|
retinoic acid induced 2 |
chr5_+_65107551 | 6.73 |
ENSMUST00000101192.2
|
Klhl5
|
kelch-like 5 |
chr6_-_48445373 | 6.72 |
ENSMUST00000114563.1
ENSMUST00000114558.1 ENSMUST00000101443.3 ENSMUST00000114564.1 |
Zfp467
|
zinc finger protein 467 |
chr17_-_28350747 | 6.72 |
ENSMUST00000080572.7
ENSMUST00000156862.1 |
Tead3
|
TEA domain family member 3 |
chr7_+_101321079 | 6.70 |
ENSMUST00000032927.7
|
Stard10
|
START domain containing 10 |
chr19_-_47464406 | 6.69 |
ENSMUST00000111800.2
ENSMUST00000081619.2 |
Sh3pxd2a
|
SH3 and PX domains 2A |
chr17_+_24736639 | 6.66 |
ENSMUST00000115262.1
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr10_-_109010955 | 6.66 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
Syt1
|
synaptotagmin I |
chr10_+_80330127 | 6.64 |
ENSMUST00000040081.6
|
Reep6
|
receptor accessory protein 6 |
chr19_-_6980420 | 6.62 |
ENSMUST00000070878.8
ENSMUST00000177752.1 |
Fkbp2
|
FK506 binding protein 2 |
chr4_+_155563700 | 6.61 |
ENSMUST00000105613.3
ENSMUST00000143840.1 ENSMUST00000146080.1 |
Nadk
|
NAD kinase |
chr5_+_130448801 | 6.61 |
ENSMUST00000111288.2
|
Caln1
|
calneuron 1 |
chr11_+_77462605 | 6.61 |
ENSMUST00000130255.1
|
Coro6
|
coronin 6 |
chr9_+_77754526 | 6.60 |
ENSMUST00000034905.8
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr10_-_59616667 | 6.60 |
ENSMUST00000020312.6
|
Mcu
|
mitochondrial calcium uniporter |
chr15_-_75566608 | 6.57 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr6_+_138140298 | 6.56 |
ENSMUST00000008684.4
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr3_+_118562129 | 6.56 |
ENSMUST00000039177.7
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr13_-_17694729 | 6.56 |
ENSMUST00000068545.4
|
5033411D12Rik
|
RIKEN cDNA 5033411D12 gene |
chr4_-_129248431 | 6.51 |
ENSMUST00000052602.5
|
C77080
|
expressed sequence C77080 |
chr9_+_119402444 | 6.51 |
ENSMUST00000035093.8
ENSMUST00000165044.1 |
Acvr2b
|
activin receptor IIB |
chr15_+_7129557 | 6.48 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr7_-_97579382 | 6.48 |
ENSMUST00000151840.1
ENSMUST00000135998.1 ENSMUST00000144858.1 ENSMUST00000146605.1 ENSMUST00000072725.5 ENSMUST00000138060.1 ENSMUST00000154853.1 ENSMUST00000136757.1 ENSMUST00000124552.1 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr15_-_76660108 | 6.47 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr6_+_138140521 | 6.46 |
ENSMUST00000120939.1
ENSMUST00000120302.1 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr18_-_56562187 | 6.45 |
ENSMUST00000171844.2
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr5_-_34187670 | 6.45 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr12_-_30373358 | 6.42 |
ENSMUST00000021004.7
|
Sntg2
|
syntrophin, gamma 2 |
chr1_+_93512079 | 6.41 |
ENSMUST00000120301.1
ENSMUST00000041983.4 ENSMUST00000122402.1 |
Farp2
|
FERM, RhoGEF and pleckstrin domain protein 2 |
chr1_-_173367638 | 6.38 |
ENSMUST00000005470.4
ENSMUST00000111220.1 |
Cadm3
|
cell adhesion molecule 3 |
chr11_-_72266596 | 6.38 |
ENSMUST00000021161.6
ENSMUST00000140167.1 |
Slc13a5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr17_+_45686322 | 6.37 |
ENSMUST00000024734.7
|
Mrpl14
|
mitochondrial ribosomal protein L14 |
chr5_+_30814722 | 6.35 |
ENSMUST00000114724.1
|
Mapre3
|
microtubule-associated protein, RP/EB family, member 3 |
chr19_+_6497772 | 6.34 |
ENSMUST00000113458.1
ENSMUST00000113459.1 |
Nrxn2
|
neurexin II |
chr9_-_107667375 | 6.31 |
ENSMUST00000010208.8
|
Slc38a3
|
solute carrier family 38, member 3 |
chr9_+_119357381 | 6.30 |
ENSMUST00000039610.8
|
Xylb
|
xylulokinase homolog (H. influenzae) |
chr15_+_81811414 | 6.29 |
ENSMUST00000023024.7
|
Tef
|
thyrotroph embryonic factor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.9 | GO:0006507 | GPI anchor release(GO:0006507) |
7.4 | 44.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
7.2 | 21.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
6.8 | 27.4 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
6.7 | 26.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
6.1 | 18.2 | GO:0048627 | myoblast development(GO:0048627) |
5.9 | 17.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
5.6 | 22.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
5.5 | 16.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
5.3 | 16.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
4.7 | 14.0 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
4.7 | 18.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
4.4 | 13.3 | GO:0097274 | urea homeostasis(GO:0097274) |
4.4 | 13.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
4.4 | 13.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
4.4 | 4.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
4.3 | 12.9 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
4.2 | 16.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
4.2 | 12.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
3.9 | 11.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
3.8 | 11.4 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
3.7 | 11.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
3.7 | 14.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.6 | 10.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
3.5 | 14.0 | GO:0061625 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.5 | 13.9 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
3.5 | 10.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
3.4 | 13.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
3.4 | 10.2 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
3.4 | 10.1 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
3.3 | 13.3 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
3.3 | 13.1 | GO:0030091 | protein repair(GO:0030091) |
3.3 | 9.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.3 | 13.0 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
3.2 | 16.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.2 | 3.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
3.1 | 9.2 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
3.0 | 12.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
3.0 | 9.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
3.0 | 11.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.9 | 25.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.9 | 8.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
2.9 | 5.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.9 | 8.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
2.8 | 28.0 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
2.7 | 8.2 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
2.6 | 7.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.6 | 2.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
2.5 | 7.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.5 | 7.5 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
2.5 | 7.5 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
2.5 | 7.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
2.5 | 12.5 | GO:0070178 | D-serine metabolic process(GO:0070178) |
2.4 | 7.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.4 | 9.6 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
2.4 | 7.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
2.4 | 2.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.4 | 2.4 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
2.4 | 9.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
2.4 | 4.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
2.3 | 7.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
2.3 | 2.3 | GO:0015744 | succinate transport(GO:0015744) |
2.3 | 6.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
2.3 | 6.8 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
2.3 | 9.0 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
2.3 | 15.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
2.2 | 11.1 | GO:0015888 | thiamine transport(GO:0015888) |
2.2 | 13.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.2 | 2.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.2 | 13.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
2.2 | 15.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.2 | 10.9 | GO:0051012 | microtubule sliding(GO:0051012) |
2.2 | 10.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.2 | 13.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.2 | 8.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.2 | 6.5 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
2.2 | 10.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.1 | 40.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
2.1 | 14.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.1 | 8.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.1 | 10.4 | GO:0070459 | prolactin secretion(GO:0070459) |
2.1 | 6.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
2.0 | 6.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
2.0 | 14.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.0 | 8.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
2.0 | 6.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.0 | 12.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.0 | 8.0 | GO:0030070 | insulin processing(GO:0030070) |
2.0 | 6.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.0 | 7.9 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
2.0 | 45.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
2.0 | 3.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.0 | 9.8 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
2.0 | 5.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.9 | 1.9 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
1.9 | 5.8 | GO:0015866 | ADP transport(GO:0015866) |
1.9 | 5.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.9 | 5.7 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
1.9 | 22.9 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.9 | 5.7 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.9 | 7.5 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.9 | 5.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.9 | 3.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.9 | 7.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.9 | 5.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.9 | 24.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.8 | 5.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.8 | 11.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.8 | 12.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.8 | 20.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.8 | 5.5 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.8 | 3.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.8 | 5.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.8 | 1.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.8 | 10.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.8 | 5.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.8 | 8.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.8 | 12.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.8 | 3.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
1.8 | 12.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 5.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.7 | 1.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.7 | 8.7 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.7 | 5.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.7 | 36.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.7 | 12.1 | GO:0001757 | somite specification(GO:0001757) |
1.7 | 13.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.7 | 6.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.7 | 13.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.7 | 8.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
1.7 | 8.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.7 | 5.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.7 | 5.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.7 | 16.9 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.7 | 5.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
1.7 | 8.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.7 | 6.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.7 | 16.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
1.7 | 5.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.6 | 11.4 | GO:0034214 | protein hexamerization(GO:0034214) |
1.6 | 4.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.6 | 13.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.6 | 3.2 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.6 | 1.6 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
1.6 | 1.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.6 | 8.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.6 | 8.0 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.6 | 11.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.6 | 3.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.6 | 6.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.6 | 22.0 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
1.6 | 4.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.6 | 9.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.6 | 4.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.6 | 3.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.6 | 7.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.6 | 14.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 10.8 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
1.5 | 4.6 | GO:1902022 | L-lysine transport(GO:1902022) |
1.5 | 4.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
1.5 | 3.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.5 | 26.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.5 | 4.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.5 | 4.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
1.5 | 6.0 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.5 | 13.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.5 | 4.5 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.5 | 3.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 5.9 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
1.5 | 13.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.5 | 11.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.4 | 4.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
1.4 | 2.9 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
1.4 | 1.4 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
1.4 | 5.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.4 | 11.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.4 | 4.2 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.4 | 5.6 | GO:0000050 | urea cycle(GO:0000050) |
1.4 | 7.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.4 | 5.6 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
1.4 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.4 | 8.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.4 | 5.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.4 | 2.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.4 | 5.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.4 | 27.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.4 | 1.4 | GO:0060596 | mammary placode formation(GO:0060596) |
1.3 | 10.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.3 | 5.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.3 | 8.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.3 | 5.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
1.3 | 5.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.3 | 6.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.3 | 4.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.3 | 4.0 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
1.3 | 2.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.3 | 6.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.3 | 9.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 3.9 | GO:0034239 | regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
1.3 | 6.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.3 | 9.1 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 2.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.3 | 1.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.3 | 22.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.3 | 3.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 9.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.3 | 2.6 | GO:0021759 | globus pallidus development(GO:0021759) |
1.3 | 19.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.3 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.3 | 3.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.3 | 7.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
1.3 | 6.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.3 | 8.9 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
1.3 | 3.8 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
1.3 | 2.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.3 | 15.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.3 | 10.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 3.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
1.3 | 5.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.3 | 8.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.3 | 3.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 5.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.2 | 6.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 12.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.2 | 4.9 | GO:0014028 | notochord formation(GO:0014028) |
1.2 | 3.7 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.2 | 9.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.2 | 7.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 19.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.2 | 12.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
1.2 | 8.5 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 2.4 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
1.2 | 6.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 3.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.2 | 3.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.2 | 4.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
1.2 | 3.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 11.9 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.2 | 4.8 | GO:0003360 | brainstem development(GO:0003360) |
1.2 | 4.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 4.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.2 | 2.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 27.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 3.5 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
1.2 | 3.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 13.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.2 | 1.2 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.2 | 5.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
1.2 | 3.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.2 | 2.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.2 | 2.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
1.2 | 7.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 3.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.2 | 3.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.2 | 2.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.2 | 9.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.1 | 18.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.1 | 5.7 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.1 | 14.9 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
1.1 | 8.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.1 | 4.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.1 | 8.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.1 | 4.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.1 | 4.5 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
1.1 | 3.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
1.1 | 4.5 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
1.1 | 4.5 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.1 | 7.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.1 | 4.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
1.1 | 2.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.1 | 4.5 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
1.1 | 8.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 5.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.1 | 4.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
1.1 | 10.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.1 | 4.4 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
1.1 | 4.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.1 | 6.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 2.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.1 | 2.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.1 | 3.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
1.1 | 3.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.1 | 6.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.1 | 4.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
1.1 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.1 | 7.6 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.1 | 4.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 10.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.1 | 5.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.1 | 2.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
1.1 | 2.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.1 | 5.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
1.1 | 17.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 37.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 28.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.1 | 3.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
1.1 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 11.7 | GO:0090003 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
1.1 | 3.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 2.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 2.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
1.1 | 8.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.0 | 4.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 4.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.0 | 8.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.0 | 5.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.0 | 1.0 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.0 | 1.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 7.1 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 4.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 2.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 1.0 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.0 | 15.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.0 | 2.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
1.0 | 1.0 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
1.0 | 4.0 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 5.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 1.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.0 | 5.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.0 | 3.0 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
1.0 | 7.9 | GO:0071569 | protein ufmylation(GO:0071569) |
1.0 | 12.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.0 | 2.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.0 | 8.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.0 | 3.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.0 | 8.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.0 | 3.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.0 | 7.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.0 | 1.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.0 | 14.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.0 | 9.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 2.9 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.0 | 2.9 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
1.0 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.0 | 1.0 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
1.0 | 2.9 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.9 | 6.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 7.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 4.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.9 | 5.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 2.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.9 | 3.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 2.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.9 | 3.7 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.9 | 8.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 2.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.9 | 2.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.9 | 1.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.9 | 0.9 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.9 | 2.8 | GO:0015881 | creatine transport(GO:0015881) |
0.9 | 3.7 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.9 | 10.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 1.8 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.9 | 3.7 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
0.9 | 4.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.9 | 1.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.9 | 2.7 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.9 | 1.8 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.9 | 4.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.9 | 2.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.9 | 1.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 4.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.9 | 3.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.9 | 1.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.9 | 8.9 | GO:0046959 | habituation(GO:0046959) |
0.9 | 1.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.9 | 4.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 2.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.9 | 3.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 10.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.9 | 5.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.9 | 5.2 | GO:0015705 | iodide transport(GO:0015705) |
0.9 | 9.6 | GO:0010225 | response to UV-C(GO:0010225) |
0.9 | 4.3 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.9 | 2.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.9 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.9 | 2.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 2.6 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.8 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 1.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.8 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.8 | 9.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.8 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.8 | 6.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.8 | 5.9 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 12.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 3.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.8 | 2.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 14.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.8 | 5.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 2.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.8 | 3.3 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.8 | 2.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.8 | 4.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.8 | 4.9 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.8 | 4.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.8 | 6.5 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.8 | 7.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 2.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.8 | 1.6 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.8 | 34.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.8 | 4.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.8 | 13.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.8 | 3.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.8 | 4.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 6.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 5.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 8.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 2.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.8 | 4.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.8 | 0.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 3.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 1.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.8 | 5.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.8 | 0.8 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.8 | 4.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.8 | 3.9 | GO:0060430 | lung saccule development(GO:0060430) |
0.8 | 1.6 | GO:0015817 | histidine transport(GO:0015817) |
0.8 | 0.8 | GO:0048597 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 12.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 2.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.8 | 3.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 1.6 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 2.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.8 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 1.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 1.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 3.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.8 | 13.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 1.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.8 | 3.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.8 | 0.8 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.8 | 3.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 3.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.7 | 3.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.7 | 9.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.7 | 0.7 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.7 | 1.5 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.7 | 3.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.7 | 4.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 2.2 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.7 | 4.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.7 | 7.2 | GO:0055093 | response to hyperoxia(GO:0055093) |
0.7 | 15.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.7 | 6.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.7 | 2.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.7 | 2.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.7 | 6.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.7 | 3.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.7 | 2.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.9 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.7 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.7 | 0.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.7 | 9.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.7 | 5.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 1.4 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.7 | 7.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.7 | 7.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.7 | 0.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.7 | 2.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.7 | 3.5 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.7 | 4.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 0.7 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.7 | 4.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.7 | 2.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.7 | 9.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 10.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 2.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 2.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.7 | 2.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 2.0 | GO:0006983 | ER overload response(GO:0006983) |
0.7 | 3.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 4.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.7 | 1.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.7 | 1.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.7 | 2.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 4.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.7 | 3.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.7 | 7.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.7 | 2.7 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.7 | 1.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 1.3 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 2.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 1.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.7 | 2.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 4.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.7 | 2.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.7 | 2.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 7.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.7 | 5.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.7 | 2.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 3.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.7 | 2.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.7 | 0.7 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.7 | 22.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.6 | 8.4 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.6 | 14.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.6 | 1.3 | GO:0060592 | mammary gland formation(GO:0060592) |
0.6 | 0.6 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.6 | 3.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 2.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 1.9 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.6 | 3.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.6 | 3.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.6 | 6.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 1.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.6 | 1.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.6 | 1.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.6 | 6.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 3.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.6 | 12.6 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.6 | 3.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 1.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 4.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 4.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 3.7 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.6 | 1.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.6 | 1.9 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.6 | 1.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.6 | 1.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 28.3 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 1.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.6 | 1.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.6 | 3.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 1.8 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.6 | 3.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 1.2 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.6 | 0.6 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.6 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.6 | 2.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.6 | 4.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.6 | 1.8 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.6 | 1.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 6.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.6 | 2.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.6 | 4.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.6 | 0.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 7.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 15.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 3.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.8 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.6 | 3.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.6 | 20.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.6 | 2.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.6 | 1.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.6 | 4.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.6 | 3.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 3.0 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.6 | 1.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 5.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.6 | 9.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.6 | 8.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 1.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.6 | 1.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.6 | 3.5 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 6.4 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 7.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.6 | 2.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.6 | 1.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 3.5 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 1.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.6 | 9.8 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 0.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.6 | 1.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.6 | 1.7 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.6 | 5.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 6.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.6 | 4.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.6 | 6.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.6 | 2.8 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 3.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.6 | 1.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 2.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.6 | 1.7 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.6 | 1.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 6.7 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 7.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 6.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 2.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 3.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 1.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 1.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.5 | 2.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 0.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.5 | 3.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 4.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.5 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.5 | 2.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 2.1 | GO:1903027 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.5 | 1.1 | GO:0021539 | subthalamus development(GO:0021539) |
0.5 | 1.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 2.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.5 | 1.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.5 | 6.4 | GO:0072189 | ureter development(GO:0072189) |
0.5 | 7.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 3.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.5 | 14.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 1.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 1.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 2.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 4.7 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
0.5 | 2.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 1.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 1.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 0.5 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.5 | 6.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.5 | 1.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 8.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.5 | 8.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.5 | 2.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.5 | 20.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 4.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 3.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 1.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.5 | 2.5 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 2.5 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.5 | 5.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 4.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.5 | 1.0 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.5 | 2.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 2.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.5 | 1.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 2.5 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) xanthine catabolic process(GO:0009115) |
0.5 | 1.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.5 | 7.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 1.5 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 0.5 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.5 | 1.0 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.5 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 2.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 11.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.5 | 1.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 6.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 4.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 4.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.5 | 1.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.5 | 17.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.5 | 3.8 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 2.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.5 | 8.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 7.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.5 | 1.4 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.5 | 0.9 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 6.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.5 | 2.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 1.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 30.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.5 | 3.7 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 6.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.5 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 3.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 1.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.5 | 2.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 5.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 2.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 1.3 | GO:0072014 | proximal tubule development(GO:0072014) |
0.4 | 1.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 2.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.4 | 2.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 3.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 0.9 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 1.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.4 | 10.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.4 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 1.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 0.9 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 3.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.4 | 2.6 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.4 | 1.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.4 | 4.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 1.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 0.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.4 | 0.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 9.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.3 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.4 | 1.7 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.4 | 0.8 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.4 | 14.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 2.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.4 | 3.4 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) |
0.4 | 2.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 1.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.4 | 2.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 5.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 5.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 14.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.4 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 4.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 5.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 6.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.4 | 5.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 7.8 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.4 | 1.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 5.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 3.3 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.4 | 0.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.4 | 0.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.4 | 1.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 2.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.4 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.4 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 1.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 1.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 2.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 4.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 0.8 | GO:1990401 | embryonic lung development(GO:1990401) |
0.4 | 4.0 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.4 | 2.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 1.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 1.2 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.4 | 0.4 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 1.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 2.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 1.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 | 2.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 1.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.4 | 1.6 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 2.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 0.8 | GO:0031179 | peptide modification(GO:0031179) |
0.4 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 5.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 4.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.4 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.1 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.4 | 3.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 3.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 2.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 0.7 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.4 | 3.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 1.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.4 | 4.0 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.4 | 0.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 5.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.4 | 0.7 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 0.7 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.4 | 0.7 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.4 | 2.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 0.7 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.4 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 0.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 4.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 3.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.3 | 1.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 17.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 3.5 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.3 | 4.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 7.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 1.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.7 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.3 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 1.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 2.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.3 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 1.0 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 1.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.3 | 2.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 3.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 3.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.3 | 2.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 1.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.3 | 0.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 7.0 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.3 | 1.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 2.9 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 8.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.6 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.3 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 2.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.3 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.3 | 0.6 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 12.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 9.6 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.3 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 1.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 3.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.5 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.3 | 2.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 0.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 0.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.3 | 0.3 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.3 | 1.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 4.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 16.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 1.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 1.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 6.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 5.5 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.3 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.3 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.3 | 4.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 1.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 3.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.3 | 0.9 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 8.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 3.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 1.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.3 | 0.3 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.3 | 2.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 1.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 10.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 2.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.3 | GO:0019230 | proprioception(GO:0019230) |
0.3 | 11.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.3 | 3.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 5.7 | GO:0007041 | lysosomal transport(GO:0007041) |
0.3 | 1.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 1.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 8.4 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.3 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.8 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.3 | 2.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.1 | GO:0035127 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.3 | 1.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.3 | 3.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 4.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 10.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 0.5 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.3 | 0.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.3 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 2.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.3 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 3.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 1.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 6.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 1.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 2.2 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.2 | 0.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.7 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.2 | 0.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 4.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.7 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 1.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.5 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 1.8 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.2 | 4.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.2 | 1.8 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
0.2 | 0.2 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 4.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 1.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 1.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 1.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 1.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 0.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 1.3 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 2.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 3.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 6.6 | GO:0071715 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 1.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 2.9 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 2.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.6 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.2 | 1.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 1.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 1.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 1.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.2 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 4.7 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.9 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.2 | 1.7 | GO:0036503 | ERAD pathway(GO:0036503) |
0.2 | 1.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 2.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 0.4 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.5 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.2 | 1.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 2.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 1.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 1.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 2.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
0.2 | 1.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 2.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.2 | 2.4 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 1.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.2 | 0.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 2.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.2 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.2 | 4.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.3 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 4.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.4 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 0.5 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.9 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 5.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 1.4 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 3.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 2.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 2.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 1.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 1.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.9 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.1 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 1.7 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.1 | 0.8 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 2.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 1.9 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 1.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 1.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 3.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 0.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.3 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.1 | 0.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 2.9 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 2.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 5.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 3.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 3.5 | GO:1905037 | autophagosome organization(GO:1905037) |
0.1 | 2.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.8 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.4 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.6 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.5 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.9 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.5 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.1 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.5 | GO:0075522 | cap-independent translational initiation(GO:0002190) IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 1.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.3 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.1 | 0.1 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
0.1 | 0.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.6 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 1.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.1 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 3.8 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 4.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 2.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.0 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.2 | GO:0009816 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 3.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.4 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 1.0 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.9 | GO:0001825 | blastocyst formation(GO:0001825) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.2 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.0 | 0.1 | GO:0019184 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0044317 | rod spherule(GO:0044317) |
4.0 | 12.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.8 | 30.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.7 | 11.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
3.4 | 3.4 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
3.3 | 6.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.1 | 15.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
2.8 | 14.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.7 | 13.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
2.4 | 19.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.2 | 34.4 | GO:0070852 | cell body fiber(GO:0070852) |
2.1 | 6.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
2.1 | 6.4 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
2.1 | 12.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
2.1 | 28.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.0 | 2.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.9 | 7.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.9 | 7.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.9 | 9.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
1.9 | 9.3 | GO:1990246 | uniplex complex(GO:1990246) |
1.8 | 7.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.8 | 14.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.8 | 12.5 | GO:0070695 | FHF complex(GO:0070695) |
1.7 | 26.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.7 | 3.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.7 | 11.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.7 | 11.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.6 | 12.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 4.7 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.5 | 16.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.5 | 5.8 | GO:0036019 | endolysosome(GO:0036019) |
1.4 | 18.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.4 | 4.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.4 | 5.7 | GO:1903349 | omegasome membrane(GO:1903349) |
1.4 | 7.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.4 | 4.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.4 | 9.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.4 | 5.6 | GO:0071942 | XPC complex(GO:0071942) |
1.4 | 5.5 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
1.4 | 37.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.4 | 8.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 10.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.3 | 25.2 | GO:0030056 | hemidesmosome(GO:0030056) |
1.3 | 3.9 | GO:0098855 | HCN channel complex(GO:0098855) |
1.3 | 7.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 1.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
1.2 | 6.2 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 3.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.2 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
1.2 | 6.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.2 | 9.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.2 | 9.6 | GO:1990357 | terminal web(GO:1990357) |
1.2 | 5.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.2 | 15.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 33.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.2 | 12.9 | GO:0016342 | catenin complex(GO:0016342) |
1.2 | 2.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.2 | 2.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.2 | 8.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.1 | 3.4 | GO:0048179 | activin receptor complex(GO:0048179) |
1.1 | 10.2 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 9.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 5.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.1 | 4.5 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
1.1 | 1.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.1 | 5.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.1 | 9.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.1 | 10.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.1 | 4.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.1 | 3.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
1.0 | 6.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.0 | 3.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.0 | 6.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.0 | 2.1 | GO:0044753 | amphisome(GO:0044753) |
1.0 | 4.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.0 | 4.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.0 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
1.0 | 2.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.0 | 16.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.9 | 19.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 1.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.9 | 13.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.9 | 5.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.9 | 5.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.9 | 1.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.9 | 5.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 19.3 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.9 | 5.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.9 | 4.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.9 | 170.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.9 | 5.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.9 | 1.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.9 | 0.9 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.8 | 5.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 3.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 17.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.8 | 0.8 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.8 | 3.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.8 | 4.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 13.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.8 | 4.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.8 | 2.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 2.3 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 4.5 | GO:0044305 | calyx of Held(GO:0044305) |
0.7 | 3.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 9.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 8.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 41.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.7 | 5.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 10.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 5.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 2.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.7 | 5.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 2.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 3.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.7 | 2.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.7 | 21.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.7 | 2.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 4.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.7 | 4.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 8.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 81.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.6 | 3.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 6.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 2.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.6 | 1.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 1.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.6 | 5.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.6 | 6.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 1.8 | GO:0018444 | translation release factor complex(GO:0018444) |
0.6 | 3.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 2.5 | GO:1990037 | Lewy body core(GO:1990037) |
0.6 | 6.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 3.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.6 | 6.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 16.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 2.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 2.3 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.6 | 17.6 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 2.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.6 | 2.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 1.7 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.6 | 2.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 6.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 2.8 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 9.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 2.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 2.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 11.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 8.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 3.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 0.5 | GO:0042025 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.5 | 2.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.5 | 2.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 5.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 19.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 1.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 9.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 5.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 3.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 4.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 3.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 2.8 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.5 | 4.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.4 | 20.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 8.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 3.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 1.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.4 | 7.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 2.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 2.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 32.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 3.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 9.7 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 1.3 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 1.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.4 | 2.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 2.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 11.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 9.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 16.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 3.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 12.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 86.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 3.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.4 | 18.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 1.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.4 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 24.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 33.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 2.7 | GO:0044754 | autolysosome(GO:0044754) |
0.4 | 14.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 1.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 18.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 3.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 7.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.4 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 4.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 11.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 2.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 1.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 4.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 20.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 7.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.3 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 37.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 12.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 4.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 3.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 6.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.9 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 1.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 2.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.3 | 1.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 61.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 18.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 6.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 3.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 2.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 3.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.1 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.3 | 2.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 2.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 36.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 1.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 1.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 2.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 7.7 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 69.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 5.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 2.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 2.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 4.1 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 9.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 7.8 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 7.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 3.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 8.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 6.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 6.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 124.6 | GO:0005768 | endosome(GO:0005768) |
0.2 | 2.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 5.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 6.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 4.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 216.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 4.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 23.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 3.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.3 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 21.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 9.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 7.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 18.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.5 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.7 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0060473 | cortical granule(GO:0060473) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.6 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 6.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.1 | 43.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 5.7 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 3.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 7.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 45.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
7.1 | 21.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
6.4 | 19.1 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
6.0 | 29.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
5.7 | 17.0 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
5.5 | 27.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
4.8 | 14.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
4.7 | 14.0 | GO:0046911 | metal chelating activity(GO:0046911) |
4.7 | 14.0 | GO:0004454 | ketohexokinase activity(GO:0004454) |
4.6 | 13.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
4.6 | 18.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
4.0 | 12.1 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
4.0 | 12.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
3.6 | 14.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
3.6 | 17.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
3.5 | 3.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
3.5 | 10.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
3.4 | 3.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
3.3 | 10.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
3.3 | 10.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.3 | 13.3 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
3.2 | 16.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.0 | 26.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.9 | 11.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.9 | 8.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.9 | 14.3 | GO:0032810 | sterol response element binding(GO:0032810) |
2.8 | 16.9 | GO:0004103 | choline kinase activity(GO:0004103) |
2.8 | 16.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.8 | 13.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.8 | 11.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
2.7 | 8.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
2.7 | 8.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
2.7 | 10.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
2.6 | 13.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
2.6 | 15.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.6 | 10.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.5 | 10.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.5 | 7.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
2.4 | 9.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
2.4 | 14.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.4 | 7.2 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
2.3 | 2.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
2.3 | 6.9 | GO:0005118 | sevenless binding(GO:0005118) |
2.3 | 9.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
2.3 | 13.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.2 | 11.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
2.2 | 6.6 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.2 | 13.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
2.2 | 4.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.2 | 6.5 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
2.1 | 6.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
2.1 | 12.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
2.1 | 12.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.1 | 8.4 | GO:0042806 | fucose binding(GO:0042806) |
2.1 | 8.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.1 | 4.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
2.1 | 12.5 | GO:0097016 | L27 domain binding(GO:0097016) |
2.1 | 6.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.1 | 14.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
2.0 | 2.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
2.0 | 12.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.0 | 7.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
2.0 | 7.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.9 | 13.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.9 | 11.6 | GO:0004359 | glutaminase activity(GO:0004359) |
1.9 | 7.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.9 | 22.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.9 | 7.6 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.9 | 9.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.9 | 17.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.9 | 17.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
1.9 | 7.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.9 | 5.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.9 | 5.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.8 | 11.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.8 | 5.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.8 | 32.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.8 | 7.3 | GO:0004096 | catalase activity(GO:0004096) |
1.8 | 5.4 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.8 | 16.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.8 | 1.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.8 | 3.5 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.8 | 7.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.8 | 17.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.7 | 6.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 15.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.7 | 5.1 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.7 | 18.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.6 | 6.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
1.6 | 4.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.6 | 4.9 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.6 | 6.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
1.6 | 4.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.5 | 6.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.5 | 1.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.5 | 4.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.5 | 7.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.5 | 5.9 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.5 | 8.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.5 | 2.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.5 | 13.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.4 | 5.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.4 | 2.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.4 | 7.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.4 | 4.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.4 | 5.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.4 | 5.7 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.4 | 5.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.4 | 5.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.4 | 13.9 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
1.4 | 15.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.4 | 15.2 | GO:0019213 | deacetylase activity(GO:0019213) |
1.4 | 9.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.4 | 6.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.4 | 4.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.4 | 13.7 | GO:0039706 | co-receptor binding(GO:0039706) |
1.4 | 2.7 | GO:0070404 | NADH binding(GO:0070404) |
1.4 | 12.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.4 | 6.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.3 | 4.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.3 | 13.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.3 | 3.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.3 | 2.5 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
1.3 | 1.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.2 | 3.7 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
1.2 | 3.7 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
1.2 | 4.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.2 | 3.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.2 | 3.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.2 | 4.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.2 | 7.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.2 | 5.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.2 | 8.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.2 | 10.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.2 | 5.8 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
1.2 | 23.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.2 | 3.5 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
1.2 | 5.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.2 | 3.5 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
1.1 | 3.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.1 | 3.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.1 | 19.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.1 | 4.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.1 | 2.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.1 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.1 | 6.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.1 | 3.4 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
1.1 | 8.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.1 | 4.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.1 | 16.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 5.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.1 | 12.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.1 | 20.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.1 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.1 | 10.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.1 | 4.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.1 | 2.1 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
1.1 | 3.2 | GO:0045159 | myosin II binding(GO:0045159) |
1.1 | 4.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
1.1 | 9.6 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
1.1 | 3.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 4.2 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
1.1 | 5.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.1 | 11.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.1 | 4.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 2.1 | GO:0038132 | neuregulin binding(GO:0038132) |
1.0 | 4.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
1.0 | 2.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.0 | 3.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
1.0 | 7.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 3.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
1.0 | 5.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.0 | 6.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 1.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.0 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 3.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.0 | 10.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.0 | 2.9 | GO:0030977 | taurine binding(GO:0030977) |
1.0 | 5.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.0 | 1.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.0 | 8.8 | GO:0043426 | MRF binding(GO:0043426) |
1.0 | 2.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.0 | 19.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.0 | 4.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.0 | 1.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 8.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 2.8 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.9 | 12.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.9 | 1.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.9 | 2.8 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.9 | 0.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.9 | 3.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 7.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 9.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.9 | 4.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.9 | 5.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.9 | 5.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 4.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.9 | 5.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.9 | 5.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.9 | 2.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.9 | 1.7 | GO:0033265 | choline binding(GO:0033265) |
0.9 | 3.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.8 | 5.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.8 | 4.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 5.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.8 | 3.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 11.6 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 2.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.8 | 4.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.8 | 22.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.8 | 3.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.8 | 2.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.8 | 9.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 16.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.8 | 7.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.8 | 39.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.8 | 7.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 1.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.8 | 3.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 3.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.8 | 3.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.8 | 3.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.8 | 3.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.8 | 6.2 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 2.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 2.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.8 | 6.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.8 | 2.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 2.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.8 | 3.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 3.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.8 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 9.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 18.7 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.7 | 2.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 1.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.7 | 2.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 3.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 2.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 17.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 3.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.7 | 10.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.7 | 4.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.7 | 11.6 | GO:0048038 | quinone binding(GO:0048038) |
0.7 | 5.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 2.9 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.7 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 11.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 2.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.7 | 4.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 5.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 4.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 3.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.7 | 2.0 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.7 | 2.7 | GO:0035276 | ethanol binding(GO:0035276) |
0.7 | 16.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.7 | 4.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 4.8 | GO:0089720 | caspase binding(GO:0089720) |
0.7 | 8.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.7 | 2.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.7 | 2.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.7 | 1.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 2.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.7 | 3.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 3.3 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 9.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.6 | 1.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.6 | 28.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.6 | 1.9 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.6 | 9.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 2.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 3.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.6 | 4.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 4.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.9 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.6 | 3.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.6 | 3.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 1.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 1.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.6 | 3.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 1.8 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.6 | 4.3 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 5.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.4 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 6.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 9.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 4.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 5.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 3.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 3.0 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.6 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 6.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.6 | 5.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 4.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 3.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.6 | 1.2 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.6 | 7.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.6 | 5.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 2.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.6 | 1.7 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.6 | 1.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.6 | 1.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.6 | 5.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 1.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.7 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.6 | 11.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.6 | 5.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 1.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 1.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.6 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 2.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.6 | 18.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 7.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 17.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 6.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 1.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 9.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 4.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 16.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 2.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 2.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 5.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.5 | 4.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 4.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 10.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 6.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 4.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 27.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 5.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 4.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.5 | 5.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.5 | 2.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 2.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.5 | 2.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 10.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 2.0 | GO:0004905 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.5 | 2.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 12.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 3.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 8.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 3.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 28.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.5 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 27.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.5 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 1.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 1.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.5 | 7.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.5 | 2.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.5 | 6.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 12.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.5 | 5.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 1.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.5 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 10.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.4 | 2.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 2.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 6.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 1.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 14.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 4.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 6.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 1.7 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.4 | 17.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 9.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 1.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 1.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 2.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 19.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 1.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.4 | 2.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 2.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 14.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 1.7 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.4 | 0.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.4 | 2.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 12.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 7.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 6.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 2.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 3.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 1.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 2.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 2.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 2.8 | GO:0015288 | porin activity(GO:0015288) |
0.4 | 1.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 6.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 11.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.4 | 5.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 2.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 17.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 3.1 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 0.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 2.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 4.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 3.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 1.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 1.1 | GO:0036478 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.4 | 4.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 6.2 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 4.7 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.4 | 1.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.4 | 5.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.4 | 1.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.4 | 4.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 11.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 2.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 7.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 3.8 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.3 | 3.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 2.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 3.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 4.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 4.3 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 2.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 6.2 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 8.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 4.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 6.1 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 1.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.3 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.3 | 2.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 3.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 1.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 6.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.3 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 12.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 5.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 2.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 1.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.3 | 5.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 7.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 3.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 3.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 21.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 1.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 2.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 2.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 2.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 5.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 2.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 7.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 3.8 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 0.8 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 1.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 1.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 1.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 4.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 5.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 6.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 2.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.3 | 2.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 3.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 19.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 3.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.3 | 1.0 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.2 | 7.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 5.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 4.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.2 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 8.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.2 | 1.0 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.2 | 3.8 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 9.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.2 | GO:0003681 | bent DNA binding(GO:0003681) |
0.2 | 1.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 3.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 2.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 1.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.6 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.2 | 4.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 2.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 13.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 1.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 1.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.2 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.6 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.2 | 6.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 5.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.5 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 13.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.2 | 2.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 3.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 4.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 3.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 6.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 7.3 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.2 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 2.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 27.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.9 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 1.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 16.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 1.3 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 2.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 14.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.7 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 4.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 3.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 2.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 4.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 5.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.1 | 1.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.1 | 4.0 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 2.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 4.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 2.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 3.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 5.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 7.0 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.8 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 1.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 2.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 36.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 3.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.9 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 7.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.4 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.9 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.1 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 3.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 3.0 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 2.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 2.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 1.3 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 4.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.4 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.8 | 14.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 71.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.1 | 2.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.1 | 11.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.0 | 24.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 49.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.9 | 47.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.9 | 10.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 3.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.9 | 19.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.9 | 28.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.8 | 4.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.8 | 10.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 19.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 36.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.7 | 31.2 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 11.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 27.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 4.1 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 3.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 28.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 3.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.6 | 15.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 15.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 6.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 9.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.5 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 1.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 1.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 10.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 3.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 8.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 21.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 32.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 2.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 3.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 12.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 4.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 3.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 10.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 3.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 2.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 7.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 20.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 6.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 2.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 6.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 12.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 3.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 7.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 4.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 14.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 7.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 4.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 12.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 8.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 2.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 6.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 5.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 3.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 5.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 10.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 2.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 12.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 4.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 14.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.6 | 56.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
2.5 | 7.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.1 | 55.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.1 | 27.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
2.0 | 44.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
2.0 | 53.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.8 | 7.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.7 | 21.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.6 | 45.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.5 | 27.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.5 | 46.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.5 | 17.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.5 | 24.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.4 | 48.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.4 | 5.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
1.2 | 2.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.2 | 22.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.2 | 41.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 7.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.2 | 7.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.2 | 13.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 31.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.1 | 14.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.1 | 94.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.1 | 19.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 1.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.1 | 2.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.0 | 12.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.0 | 12.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.0 | 13.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.0 | 11.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.0 | 15.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 10.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.0 | 12.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.0 | 29.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.9 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 17.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.9 | 29.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 17.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.9 | 17.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.9 | 2.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.9 | 18.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 15.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.9 | 16.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.8 | 21.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 1.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 17.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.8 | 7.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.8 | 13.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 13.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.7 | 1.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.7 | 9.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.7 | 14.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 6.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 5.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 15.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.7 | 13.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 10.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 9.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 1.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 3.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 6.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 9.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 20.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 15.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.5 | 4.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 6.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 5.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 6.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 86.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 5.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 9.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 3.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 1.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 8.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 8.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 3.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 7.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 5.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 7.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 3.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 3.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 9.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 3.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 23.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 3.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 4.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 7.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 9.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 14.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 2.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 2.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 9.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 17.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 3.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 2.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 2.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 18.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 4.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 7.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 1.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.3 | 6.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 1.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 5.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 11.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.3 | 6.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 6.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 28.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 11.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 8.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 4.0 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 8.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 16.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 3.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 9.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 4.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 3.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 4.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 3.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 2.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 5.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 6.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 2.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 2.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 4.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 17.7 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |